ATTUNE
Device
DePuy Synthes Products LLC
Total Payments
$267.7M
Transactions
25,747
Doctors
4,101
Companies
11
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $30.4M | 2,180 | 610 |
| 2023 | $35.0M | 2,596 | 824 |
| 2022 | $34.2M | 1,571 | 347 |
| 2021 | $36.4M | 3,105 | 891 |
| 2020 | $30.8M | 2,184 | 591 |
| 2019 | $38.3M | 5,204 | 1,342 |
| 2018 | $28.7M | 5,709 | 1,326 |
| 2017 | $34.0M | 3,198 | 917 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $242.9M | 1,296 | 90.7% |
| Consulting Fee | $14.7M | 3,752 | 5.5% |
| Unspecified | $7.2M | 1,943 | 2.7% |
| Travel and Lodging | $1.9M | 4,419 | 0.7% |
| Food and Beverage | $746,443 | 14,286 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $334,685 | 35 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,586 | 6 | 0.0% |
| Grant | $19,213 | 2 | 0.0% |
| Education | $3,286 | 5 | 0.0% |
| Gift | $52.50 | 3 | 0.0% |
Payments by Type
General
$260.6M
23,804 transactions
Research
$7.2M
1,943 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| General Outcomes Registry | Medical Device Business Services, Inc. | $1.7M | 0 |
| Multi Center Clinical Evaluation of the ATTUNE Cementless Rotating Platform Total Knee Arthroplasty | Medical Device Business Services, Inc. | $541,209 | 0 |
| Short, Medium and Long Term Survivorship of Attune Primary Total Knee Prostheses | Medical Device Business Services, Inc. | $517,063 | 1 |
| General Outcomes Registry of Hip Arthroplasty Using a DePuy Total Hip System | Medical Device Business Services, Inc. | $479,225 | 0 |
| Joint Registry - General Outcomes DePuy Outcomes Tracking System (DOTS) | Medical Device Business Services, Inc. | $435,725 | 0 |
| Joint Registry General Outcomes DePuy Outcomes Tracking System | Medical Device Business Services, Inc. | $322,750 | 0 |
| Short Medium and Long Term Survivorship of Attune Primary Total Knee Prostheses | Medical Device Business Services, Inc. | $319,814 | 1 |
| Multi-Center Clinical Evaluation of the ATTUNE Cementless Fixed Bearing Tibial Base Cementless Patella Implants in Total Knee Arthroplasty | Medical Device Business Services, Inc. | $217,309 | 0 |
| Multi-Center Clinical Evaluation of the ATTUNE Revision System in Complex Primary Total Knee Arthroplasty | Medical Device Business Services, Inc. | $216,127 | 0 |
| Attune Revision RTKA Population Multi Center Clinical Evaluation of the Attune Revision System in Complex Primary Total Knee Arthroplasty | Medical Device Business Services, Inc. | $213,374 | 0 |
| Multi-Center Clinical Evaluation of the ATTUNE Revision System in Revision Total Knee Arthroplasty | Medical Device Business Services, Inc. | $212,867 | 0 |
| OUTCOMES OF KNEE ARTHROPLASTY USING THE DEPUY ATTUNE ALL POLY TIBIA KNEE IMPLANT | Medical Device Business Services, Inc. | $192,775 | 0 |
| Multi-Center Clinical Investigation of the ATTUNE Cementless Fixed Bearing Tibial Base and Cementless Patella Implants in Total Knee Arthroplasty | Medical Device Business Services, Inc. | $124,610 | 0 |
| Multi Center Clinical Evaluation of the ATTUNE Revision System in Revision Total Knee Arthroplasty | Medical Device Business Services, Inc. | $121,534 | 0 |
| Joint Registry General Outcomes DePuy Outcomes Tracking System | Medical Device Business Services, Inc. | $102,150 | 0 |
| Comparison of Alignment achieved using Single-Use versus Reusable Instrumentation in Total Knee Arthroplasty (TKA): A Prospective, Non Randomized Multi-center Investigation | Medical Device Business Services, Inc. | $96,059 | 0 |
| OUTCOMES OF KNEE ARTHROPLASTY USING THE DEPUY ATTUNE Medial Stabilized Insert | Medical Device Business Services, Inc. | $88,425 | 0 |
| Short, Medium and Long Term Survivorship of Attune Primary Total Knee Prostheses Clinical Research Study | Medical Device Business Services, Inc. | $72,750 | 0 |
| Prospective, Single Arm Multiconfiguration Investigation to Assess the Functional Performance of Attune Primary Total Knee Arthroplasty System | Medical Device Business Services, Inc. | $70,896 | 1 |
| Attune Revision - RTKA Population: Multi Center Clinical Evaluation of the Attune Revision System in Complex Primary Total Knee Arthroplasty | Medical Device Business Services, Inc. | $69,088 | 0 |
Ad
Manufacturing Companies
- DePuy Synthes Products, Inc. $190.6M
- DePuy Synthes Products LLC $56.9M
- Medical Device Business Services, Inc. $19.2M
- DePuy Synthes Sales Inc. $843,368
- Ethicon Inc. $49,112
- Johnson & Johnson Medical Devices & Diagnostics Group - Latin America, L.L.C. $26,131
- Ethicon Endo-Surgery Inc. $9,725
- Ethicon US, LLC $7,263
- Johnson and Johnson International $6,758
- Johnson & Johnson Health Care Systems Inc. $5,865
- Abbott Laboratories $48.09
Product Information
- Type Device
- Total Payments $267.7M
- Total Doctors 4,101
- Transactions 25,747
About ATTUNE
ATTUNE is a device associated with $267.7M in payments to 4,101 healthcare providers, recorded across 25,747 transactions in the CMS Open Payments database. The primary manufacturer is DePuy Synthes Products LLC.
Payment data is available from 2017 to 2024. In 2024, $30.4M was paid across 2,180 transactions to 610 doctors.
The most common payment nature for ATTUNE is "Royalty or License" ($242.9M, 90.7% of total).
ATTUNE is associated with 20 research studies, including "General Outcomes Registry" ($1.7M).